A study to look at a new medicine called “UTTR1147A” - how safe are different doses for healthy people and patients to take – and how is this medicine processed through the body
A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)
-
Autoimmune Disorder -
Inflammatory Bowel Disease (IBD) -
Ulcerative Colitis -
Healthy Volunteers
For the latest version of this information please go to www.forpatients.roche.com